Quadrant Capital »

4d Molecular Therapeutics In shares owned by Quadrant Capital

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $713 95 7.51
2025-09-30 $825 95 8.69
2024-12-31 $2.6k 463 5.57

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Schwab Strategic Tr Fundamental Us L (FNDX)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Quadrant Capital

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In